CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application

Gerold Untergasser1, Ruth Koeck, Dominik Wolf

  • 1Tumor Biology and Angiogenesis Laboratory, Division of Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria. gerold.untergasser@uibk.ac.at

Summary

Circulating endothelial precursor cells (CEP) are easily expanded and retain an endothelial phenotype. These cells home to ischemic tissue, suggesting their potential for treating ischemic diseases and targeting tumors.

Related Concept Videos